The Onco'Zine Brief
A 100% Independent Radio broadcast and podcast concept developed for Public Radio
A Passion for Health
The Onco'Zine Brief, a 100% independent radio broadcast/podcast concept developed for Public Radio by Sunvalley Communication, is unique, informative and educational program about cancer and cancer treatment.
The Onco'Zine Brief is generally studio based. However, a number of broadcast programs and podcast will be brought from international medical society meetings in the United States and Europe, including the annual meeting of the American Association for Cancer Research (AACR), American Society of Clinical Research (ASCO), American Society of Hematology (ASH).
Each program includes interviews and stories ranging from personal stories from cancer survivors and patient advocates to discussions with Key Opinion Leaders (KOls) about cancer research, diagnostics, treatment & prevention and the business of cancer care.
In addition, some programs brought from international society meetings are designed as round tables.
The Onco'Zine Brief is available via PRX | Public Radio Exchange, iHeart Radio and, as a podcast, via iTunes, Spreaker, Stitcher, and Google and other national and international streaming media and podcast networks.
In Arizona the program can be heard every Saturday at 1 p.m. (Arizona Mountain Time) on Independent Talk 1100 KFNX, one of the top Ten Radio Stations in Arizona reaching almost 5 million people throughout Arizona. And in the United Kingdom the program is broadcast via UK Healthradio.
In addition to the regular programming, our presentation team produces many hours additional programming to be distributed as part of The Onco'Zine Dossier via iTunes.
Program page Listen to the latest episodes of The Onco'Zine Brief on PRX or The Onco'Zine Brief on iHeart Radio.
Who is listening to The Onco'Zine Brief?
For more information about upcoming programs. For more information about sponsorship and underwriting, contact our sales team.
Copyright © 2010 -2020 Sunvalley Communication, LLC. All rights reserved.
Last Editorial Review: October 29, 2020
Last Page update: October 29, 2020